|Signatures of mutational processes in human cancer|
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
|The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups|
C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ...
Nature 486 (7403), 346-352, 2012
|Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer|
MF Fraga, E Ballestar, A Villar-Garea, M Boix-Chornet, J Espada, ...
Nature genetics 37 (4), 391-400, 2005
|Analysis of circulating tumor DNA to monitor metastatic breast cancer|
SJ Dawson, DWY Tsui, M Murtaza, H Biggs, OM Rueda, SF Chin, ...
New England Journal of Medicine 368 (13), 1199-1209, 2013
|The clonal and mutational evolution spectrum of primary triple-negative breast cancers|
SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ...
Nature 486 (7403), 395-399, 2012
|International network of cancer genome projects|
International Cancer Genome Consortium
Nature 464 (7291), 993, 2010
|The landscape of cancer genes and mutational processes in breast cancer|
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
|Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA|
M Murtaza, SJ Dawson, DWY Tsui, D Gale, T Forshew, AM Piskorz, ...
Nature 497 (7447), 108-112, 2013
|Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma|
C Caldas, SA Hahn, LT Da Costa, MS Redston, M Schutte, AB Seymour, ...
Nature genetics 8 (1), 27-32, 1994
|Landscape of somatic mutations in 560 breast cancer whole-genome sequences|
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
|Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution|
SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ...
Nature 461 (7265), 809-813, 2009
|Molecular classification and molecular forecasting of breast cancer: ready for clinical application?|
JD Brenton, LA Carey, AA Ahmed, C Caldas
Journal of clinical oncology 23 (29), 7350-7360, 2005
|Differential oestrogen receptor binding is associated with clinical outcome in breast cancer|
CS Ross-Innes, R Stark, AE Teschendorff, KA Holmes, HR Ali, ...
Nature 481 (7381), 389-393, 2012
|MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype|
C Blenkiron, LD Goldstein, NP Thorne, I Spiteri, SF Chin, MJ Dunning, ...
Genome biology 8 (10), R214, 2007
|Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA|
T Forshew, M Murtaza, C Parkinson, D Gale, DWY Tsui, F Kaper, ...
Science translational medicine 4 (136), 136ra68-136ra68, 2012
|Genetic unmasking of an epigenetically silenced microRNA in human cancer cells|
A Lujambio, S Ropero, E Ballestar, MF Fraga, C Cerrato, F Setién, ...
Cancer research 67 (4), 1424-1429, 2007
|Liquid biopsies come of age: towards implementation of circulating tumour DNA|
JCM Wan, C Massie, J Garcia-Corbacho, F Mouliere, JD Brenton, ...
Nature Reviews Cancer 17 (4), 223, 2017
|Patient-derived xenograft models: an emerging platform for translational cancer research|
M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ...
Cancer discovery 4 (9), 998-1013, 2014
|Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 …|
FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ...
PLoS med 7 (5), e1000279, 2010
|The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes|
B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ...
Nature communications 7 (1), 1-16, 2016